ATV/r

DRUG3 trials

Sponsors

Community Research Initiative of New England, The HIV Netherlands Australia Thailand Research Collaboration, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Conditions

HIV InfectionsHIV-1 Infection

Phase 2

Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

CompletedNCT01903031

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsHIV-1 Infection

Start: 2014-12-30End: 2016-10-10Updated: 2018-06-06

Phase 4

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

CompletedNCT00756730

Community Research Initiative of New EnglandHIV Infections

Start: 2008-09-30End: 2011-06-30Updated: 2017-08-21

Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)

CompletedNCT01159223

The HIV Netherlands Australia Thailand Research CollaborationHIV Infections

Start: 2011-05-31End: 2015-06-30Updated: 2016-08-18

Related Papers

Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study.

2019-09-0118 citations

Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial.

2016-05-2418 citations